Digital medical company AliveCor is preparing to conduct clinical trials for its project. The company's product is an electrocardiograph device that can be connected to a smartphone. According to information from the National Institutes of Health's registry website ClinicalTrials.gov., AliveCor will randomly search for 300 trials at Columbia University to test the ability of products to remotely monitor atrial fibrillation. Monitoring equipment is fast, helping patients better understand the condition AliveCor's device is a wireless single-lead mobile electrocardiograph that can record heart rate on the back of a smartphone. It can diagnose data within 12 seconds of reading data and store the read data on the iPhone. Upload the data to a cloud-based server that patients and doctors can access. The device was approved by the FDA in 2012 and is compatible with iPhone, iPad and Android devices. AliveCor can get about 130,000 ECG data per month. 70% of users will continue to use it after 6 months of regular use of the device. At the same time, AliveCor has an application called AliveECG that can be connected to the device so that patients can keep an eye on their health. Atrial fibrillation is the most common persistent arrhythmia. As the incidence of atrial fibrillation increases with age, people over the age of 75 can reach 10%. The frequency of atrial activation during atrial fibrillation is 300-600 beats/min. People with atrial fibrillation lose their effective contractile function. The heart rate is often fast and irregular. It is not only much faster than normal people's heartbeat, but also absolutely untidy. In atrial fibrillation, the atrium loses its contractile function, and the blood is easily stagnated in the atrium to form a blood clot. After the thrombus falls off, it can accompany the blood to all parts of the body, leading to cerebral embolism and limb arterial embolization. A clinical trial researcher said: "Atrial fibrillation is an irregular heartbeat and a very serious health problem. The long-term goal of the AliveCor project is to use this heart health monitor for mobile devices to help patients better. Get a good understanding of your own atrial fibrillation and improve your ability to solve health problems."
In 2019, the New Coronary Pneumonia virus raged all over the world. Our company produced many anti-epidemic materials, including nucleic acid detection reagents, antibody detection reagents, colloidal gold, disposable civilian masks, KN95 masks, gloves, surgical clothes, ventilator, N95 medical masks, Sexual medical masks, frontal temperature guns, face masks, KN95 masks with breathing valves, disposable medical surgical masks, etc., protective clothing, isolation clothing, nucleic acid detection reagents, exported all over the world, help people around the world resist the epidemic, hope to overcome the epidemic as soon as possible Back to normal.
In 2019, the New Coronary Pneumonia virus raged all over the world. Our company produced many anti-epidemic materials, including nucleic acid detection reagents, antibody detection reagents, colloidal gold, disposable civilian masks, KN95 masks, gloves, surgical clothes, ventilator, N95 medical masks, Sexual medical masks, frontal temperature guns, face masks, KN95 masks with breathing valves, disposable medical surgical masks, etc., protective clothing, isolation clothing, nucleic acid detection reagents, exported all over the world, help people around the world resist the epidemic, hope to overcome the epidemic as soon as possible Back to normal.
Disposable protective mask
Disposable medical protective clothing
Frontal temperature guns
Disposable nitrile gloves
Medical Kn95 Mask,Disposable Medical Gowns,Disposable Protective Clothing,Infrared Forehead Thermometer Guangzhou Zhongzhinan Supply Chain Co.,Ltd. , https://www.gzzhongzhinan.com
AliveCor has a new move: conducting a clinical trial of remote atrial fibrillation monitoring
Disposable civilian KN95 mask